Items for Mahalatchimy, Aurelie

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 7.


Faulkner, Alex and Mahalatchimy, Aurelie (2018) The politics of valuation and payment for regenerative medicine products in the UK. New Genetics and Society. ISSN 1463-6778

Mahalatchimy, Aurelie and Faulkner, Alex (2017) The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics. Regenerative Medicine, 12 (6). pp. 611-622. ISSN 1746-0751

Mahalatchimy, Aurelie (2016) Reimbursement of cell- based regenerative therapy in the UK and France. Medical Law Review, 24 (2). pp. 234-258. ISSN 0967-0742

Chabannon, C, Caunday-rigot, O, Faucher, C, Slaper-Cortenbach, I, Calmels, B, Lemarie, C, Mahalatchimy, Aurelie, Mcgrath, E and Rial-Sebbag, E (2016) Accreditation and regulations in cell therapy. ISBT Science Series, 11 (Supp 1). pp. 271-276. ISSN 1751-2816

Gardner, John, Faulkner, Alex, Mahalatchimy, Aurelie and Webster, Andrew (2015) Are there specific translational challenges in regenerative medicine? Lessons from other fields. Regenerative Medicine, 10 (7). pp. 885-895. ISSN 1746-0751

Mahalatchimy, Aurelie, Rial-Sebbag, Emmanuelle, Duguet, Anne-Marie, Taboulet, Florence and Cambon-Thomsen, Anne (2015) The impact of European embryonic stem cell patent decisions on research strategies. Nature biotechnology, 33 (1). pp. 41-43. ISSN 1546-1696

Book Section

Brosset, Estelle and Mahalatchimy, Aurelie EU law and policy on new health technologies. In: Hervey, Tamara K and Young, Calum A (eds.) Research Handbook in EU Health Law and Policy. Edward Elgar. (Submitted)

This list was generated on Tue Jun 6 04:07:26 2023 BST.